A detailed history of Apg Asset Management N.V. transactions in Exact Sciences Corp stock. As of the latest transaction made, Apg Asset Management N.V. holds 64,647 shares of EXAS stock, worth $2.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
64,647
Previous 130,722 50.55%
Holding current value
$2.79 Million
Previous $9.67 Million 53.84%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$56.27 - $73.77 $3.72 Million - $4.87 Million
-66,075 Reduced 50.55%
64,647 $4.46 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $565,499 - $725,019
-9,575 Reduced 6.82%
130,722 $9.67 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $1.03 Million - $1.55 Million
-15,632 Reduced 10.03%
140,297 $9.57 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $207,721 - $314,995
-3,314 Reduced 2.08%
155,929 $14.6 Million
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $1.17 Million - $1.76 Million
-24,823 Reduced 13.49%
159,243 $10.8 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $4.57 Million - $8 Million
150,515 Added 448.62%
184,066 $9.11 Million
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $8.46 Million - $13.1 Million
-264,544 Reduced 88.74%
33,551 $1.11 Million
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $514,350 - $1.1 Million
14,444 Added 5.09%
298,095 $11.2 Million
Q1 2022

May 12, 2022

SELL
$57.56 - $82.54 $80,584 - $115,556
-1,400 Reduced 0.49%
283,651 $17.8 Million
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $253,750 - $352,380
-3,500 Reduced 1.21%
285,051 $19.5 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $2.22 Million - $3.05 Million
-24,600 Reduced 7.86%
288,551 $23.8 Million
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $1.58 Million - $2.35 Million
16,900 Added 5.7%
313,151 $32.8 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $6.55 Million - $8.71 Million
56,180 Added 23.4%
296,251 $33.2 Million
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $644,177 - $919,090
-6,467 Reduced 2.62%
240,071 $26 Million
Q3 2020

Nov 12, 2020

BUY
$72.92 - $102.01 $4.45 Million - $6.23 Million
61,051 Added 32.91%
246,538 $21.4 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $648,595 - $1.08 Million
-11,634 Reduced 5.9%
185,487 $14.4 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $7.47 Million - $20.6 Million
197,121 New
197,121 $11.4 Million
Q1 2020

May 14, 2020

SELL
$37.9 - $104.44 $5.13 Million - $14.1 Million
-135,421 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$77.66 - $99.74 $1.54 Million - $1.97 Million
19,800 Added 17.12%
135,421 $11.2 Million
Q3 2019

Nov 08, 2019

BUY
$90.37 - $122.49 $9.53 Million - $12.9 Million
105,421 Added 1033.54%
115,621 $9.58 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $913,002 - $1.2 Million
10,200 New
10,200 $1.06 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.